다음과 같은 기능을 한번의 로그인으로 사용 할 수 있습니다.
NTIS 바로가기
Neuroscience, v.101 no.4, 2000년, pp.1029 - 1036
Romero-Ramos, M (Departamento de Bioquı) , Venero, J.L (́) , Santiago, M (mica, Bromatologı) , Rodriguez-Gómez, J.A (́) , Vizuete, M.L (a, Toxicologı) , Cano, J (́) , Machado, A (a y Medicina Legal, Facultad de Farmacia, Universidad de Sevilla, Calle Profesor Garcı)
AI-Helper
AbstractWe have evaluated the effect of a vitamin E-deficient diet on the rat nigrostriatal dopaminergic system. After 15days of deficient diet, the amount and activity of striatal and nigral tyrosine hydroxylase increased, which contrasted with a decreased messenger RNA expression for tyrosine hydr...
Brain Res. Rev. Bains 25 335 1997 10.1016/S0165-0173(97)00045-3 Neurodegenerative disorders in humans: the role of glutathione in oxidative stress-mediated neuronal death
Ann. N. Y. Acad. Sci. Burton 570 7 1989 10.1111/j.1749-6632.1989.tb14904.x Vitamin E as an in vitro and in vivo antioxidant
Neuroscience Castano 53 179 1993 10.1016/0306-4522(93)90296-R Effect of a short period of vitamin E deficient diet in the turnover of different neurotransmitters in substantia nigra and striatum of the rat
Brain Res. Rev. Connor 27 1 1998 10.1016/S0165-0173(98)00004-6 The role of neuronal growth factors in neurodegenerative disorders of the human brain
NeuroReport Dexter 5 1773 1994 10.1097/00001756-199409080-00022 Nigral dopaminergic cell loss in vitamin E deficient rats
Ann. Neurol. Dexter 35 298 1994 10.1002/ana.410350309 Nigrostriatal function in vitamin E deficiency: clinical, experimental and PET studies
Neuroscience Diaz 65 731 1995 10.1016/0306-4522(94)00527-C Phenotypical characterisation of neurons expressing the dopamine D3 receptor in the rat brain
J. biol. Chem. Evens 76 273 1928 10.1016/S0021-9258(18)84127-8 Development of paralysis in the suckling young mothers deprived of vitamin E
Proc. natn. Acad. Sci. USA Grima 82 671 1985 10.1073/pnas.82.2.617 Complete code sequence of a rat tyrosine hydroxylase mRNA
J. Neurochem. Halliwell 59 1609 1992 10.1111/j.1471-4159.1992.tb10990.x Reactive oxygen species and the central nervous system
Neurology, Suppl. Jenner 47 S161 1996 10.1212/WNL.47.6_Suppl_3.161S Oxidative stress and the pathogenesis of Parkinson’s disease
Nature, Lond. Laemmli 227 680 1970 10.1038/227680a0 Cleavage of structural proteins during the assembly of the head of bacteriophage T4
Analyt. Biochem. Lenz 177 419 1989 10.1016/0003-2697(89)90077-8 Determination of carbonyl groups in oxidatively modified proteins by reduction with tritiated sodium borohydride
Meth. Enzym. Levine 186 464 1990 10.1016/0076-6879(90)86141-H Determination of carbonyl content in oxidatively modified proteins
Science Lewin 236 1420 1985 10.1126/science.3109033 Drug trial for Parkinson’s
Archs Biochem. Biophys. Liu 302 118 1993 10.1006/abbi.1993.1189 Monoamime metabolism provides an antioxidant defense in the brain against oxidant- and free radical-induced damage
J. biol. Chem. Lowry 193 265 1951 10.1016/S0021-9258(19)52451-6 Protein measurement with the Folin phenol reagent
Curr. Opin. Neurobiol. Lozano 8 783 1998 10.1016/S0959-4388(98)80122-0 New developments in understanding the etiology of Parkinson’s disease and its treatment
Fedn Proc. Mason 36 1906 1977 The first two decades of vitamin E
Lancet Muller 1 225 1983 10.1016/S0140-6736(83)92598-9 Vitamin E and neurological function
Neuroscience Murray 60 37 1994 10.1016/0306-4522(94)90202-X Differential regulation of brain-derived neurotrophic factor and type II calcium/calmodulin-dependent protein kinase messenger RNA expression in Alzheimer’s disease
NeuroReport Narisawa-Saito 7 2925 1996 10.1097/00001756-199611250-00024 Regional specificity of alterations in NGF, BDNF and NT-3 levels in Alzheimer’s disease
Pharmac. Res. Pasinetti 21 299 1989 10.1016/S1043-6618(89)80008-8 Combined in situ hybridisation and immunocytochemistry in the assay of the pharmacological effects on tyrosine hydroxylase mRNA concentration
Molec. Brain Res. Pasinetti 5 203 1989 10.1016/0169-328X(89)90036-3 Chronic lesions differentially decrease tyrosine hydroxylase messenger RNA in dopaminergic neurons of the substantia nigra
Molec. Brain Res. Pasinetti 13 63 1992 10.1016/0169-328X(92)90045-D Slow changes of tyrosine hydroxylase gene expression in dopaminergic brain neurons after neurotoxin lesioning: a model for neuron aging
Paxinos 1986 The Rat Brain in Stereotaxic Coordinates
Neuron Phillips 7 695 1991 10.1016/0896-6273(91)90273-3 BDNF mRNA is decreased in the hippocampus of individuals with Alzheimer’s disease
Life Sci. Reinhard 39 2185 1986 10.1016/0024-3205(86)90395-4 A rapid and sensitive assay for tyrosine-3-monooxygenase based upon the release of 3H2O and adsorption of (3H)tyrosine by charcoal
Molec. Brain Res. Rodriguez-Gomez 46 31 1997 10.1016/S0169-328X(96)00270-7 Deprenyl induces the tyrosine hydroxylase enzyme in the rat dopaminergic nigrostriatal system
New Engl. J. Med. Roseblum 304 503 1981 10.1056/NEJM198102263040902 A progressive neurologic syndrome with chronic liver disease
A. Rev. Pharmac. Toxic. Simonian 36 83 1996 10.1146/annurev.pa.36.040196.000503 Oxidative stress in neurodegenerative disease
Am. J. Med. Sobrevilla 57 821 1964 10.1016/0002-9343(64)90030-0 Demyelinating central nervous system disease, macular atrophy and acanthocytosis (Bassen-Kornzweig syndrome)
Free Radic. Biol. Med. Sokol 6 189 1989 10.1016/0891-5849(89)90117-2 Vitamin E and neurologic function in man
Mayo Clin. Proc. Southorn 63 390 1988 10.1016/S0025-6196(12)64862-9 Free radicals in medicine. II: Involvement in human disease
Free Radic. Biol. Med. Stadtman 9 315 1990 10.1016/0891-5849(90)90006-5 Metal-ion catalyzed oxidation of protein biochemical mechanism and biological consequences
Eur. J. Pharmac. Stoof 375 75 1999 10.1016/S0014-2999(99)00260-5 Leads for the development of neuroprotective treatment in Parkinson’s disease and brain imaging methods for estimating treatment efficacy
Brain Res. Venero 672 153 1995 10.1016/0006-8993(94)01368-R Intrastriatal quinolinic acid injections protect against 6-hydroxydopamine-induced lesions of the dopaminergic nigrostriatal system
J. Neurochem. Venero 68 2458 1997 10.1046/j.1471-4159.1997.68062458.x Time course changes in the dopaminergic nigrostriatal system following transection of the medial forebrain bundle: detection of oxidatively modified proteins in substantia nigra
Neurobiol. Aging Volicer 11 567 1990 10.1016/0197-4580(90)90119-K Involvement of free radicals in dementia of Alzheimer type: a hypothesis
J. Neurosci. Weiser 13 3472 1993 10.1523/JNEUROSCI.13-08-03472.1993 Differential spatial and temporal gene expression in response to axotomy and deafferation of the medial forebrain bundle
Molec. Brain Res. Weiser 17 319 1993 10.1016/0169-328X(93)90017-J Axotomy induced differential gene induction in neurons of the locus coeruleus and substantia nigra
*원문 PDF 파일 및 링크정보가 존재하지 않을 경우 KISTI DDS 시스템에서 제공하는 원문복사서비스를 사용할 수 있습니다.
Copyright KISTI. All Rights Reserved.
※ AI-Helper는 부적절한 답변을 할 수 있습니다.